Nothing Special   »   [go: up one dir, main page]

DD204920A5 - Verfahren zur herstellung von 8-halogenalkyl-4h-(1)-benzopyran-4-onen - Google Patents

Verfahren zur herstellung von 8-halogenalkyl-4h-(1)-benzopyran-4-onen Download PDF

Info

Publication number
DD204920A5
DD204920A5 DD82245220A DD24522082A DD204920A5 DD 204920 A5 DD204920 A5 DD 204920A5 DD 82245220 A DD82245220 A DD 82245220A DD 24522082 A DD24522082 A DD 24522082A DD 204920 A5 DD204920 A5 DD 204920A5
Authority
DD
German Democratic Republic
Prior art keywords
singlet
general formula
group
mol
molecular weight
Prior art date
Application number
DD82245220A
Other languages
German (de)
English (en)
Inventor
Briet
Berthelon
Collonges
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of DD204920A5 publication Critical patent/DD204920A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DD82245220A 1981-11-25 1982-11-25 Verfahren zur herstellung von 8-halogenalkyl-4h-(1)-benzopyran-4-onen DD204920A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8122019A FR2516921A1 (fr) 1981-11-25 1981-11-25 Haloalkyl-8-4h-(1) benzopyran-4-ones, et procedes de preparation

Publications (1)

Publication Number Publication Date
DD204920A5 true DD204920A5 (de) 1983-12-14

Family

ID=9264330

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82245220A DD204920A5 (de) 1981-11-25 1982-11-25 Verfahren zur herstellung von 8-halogenalkyl-4h-(1)-benzopyran-4-onen

Country Status (24)

Country Link
EP (1) EP0080419B1 (da)
JP (1) JPS5896038A (da)
AR (1) AR243249A1 (da)
AT (1) ATE49760T1 (da)
AU (1) AU563066B2 (da)
CA (1) CA1197511A (da)
CS (1) CS236696B2 (da)
DD (1) DD204920A5 (da)
DE (1) DE3280092D1 (da)
DK (1) DK166778B1 (da)
ES (1) ES8308322A1 (da)
FR (1) FR2516921A1 (da)
HU (1) HU194549B (da)
IE (1) IE56916B1 (da)
IL (1) IL67290A0 (da)
IN (1) IN158942B (da)
MA (1) MA19649A1 (da)
NO (1) NO162463C (da)
NZ (1) NZ202595A (da)
OA (1) OA07256A (da)
PT (2) PT75885A (da)
SU (2) SU1189344A3 (da)
YU (1) YU43808B (da)
ZA (1) ZA828435B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002603A (en) * 1989-12-04 1991-03-26 Board Of Trustees Operating Michigan State University Method and compositions for stimulating vesicular-arbuscular mycorrhizal fungi
WO1998027080A1 (en) * 1996-12-19 1998-06-25 Agrevo Uk Limited Chromones useful as fungicides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1270567B (de) * 1961-05-19 1968-06-20 Klinge Co Chem Pharm Fab Verfahren zur Herstellung von basisch substituierten Flavonen
HU168753B (da) * 1974-05-03 1976-07-28
FR2291745A1 (fr) * 1974-11-20 1976-06-18 Lipha Nouveaux acides inferieurs substitues par un radical chromonyl, leurs derives et leurs applications
FR2326919A2 (fr) * 1975-10-10 1977-05-06 Lipha Nouveaux acides inferieurs substitues par un radical chromonyle, leurs derives et leurs applications
US3966770A (en) * 1975-03-25 1976-06-29 Smithkline Corporation 4-Hydroxy-α-[(3,4-methylenedioxyphenyl)isopropylaminoethyl]-3-(methylsulfonylmethyl)benzyl alcohol
FR2392018A1 (fr) * 1977-05-27 1978-12-22 Seuref Ag Derives de la 2,3-diphenyl-chromone, leur procede de preparation et leur application therapeutique
FR2517142A1 (fr) * 1981-11-20 1983-05-27 Efcis Bascule bistable a stockage non volatil et a repositionnement statique

Also Published As

Publication number Publication date
ZA828435B (en) 1983-09-28
AU563066B2 (en) 1987-06-25
DE3280092D1 (de) 1990-03-01
DK166778B1 (da) 1993-07-12
SU1189344A3 (ru) 1985-10-30
YU43808B (en) 1989-12-31
DK522982A (da) 1983-05-26
EP0080419A2 (fr) 1983-06-01
NZ202595A (en) 1986-02-21
AU9072882A (en) 1983-06-02
NO162463C (no) 1990-01-10
CA1197511A (fr) 1985-12-03
NO823939L (no) 1983-05-26
NO162463B (no) 1989-09-25
JPS5896038A (ja) 1983-06-07
ATE49760T1 (de) 1990-02-15
SU1232146A3 (ru) 1986-05-15
MA19649A1 (fr) 1983-07-01
IE822753L (en) 1983-05-25
OA07256A (fr) 1984-04-30
IL67290A0 (en) 1983-03-31
IE56916B1 (en) 1992-01-29
EP0080419A3 (en) 1983-10-12
FR2516921B1 (da) 1984-02-10
CS236696B2 (en) 1985-05-15
ES517636A0 (es) 1983-08-16
ES8308322A1 (es) 1983-08-16
IN158942B (da) 1987-02-21
PT75886A (fr) 1982-12-01
FR2516921A1 (fr) 1983-05-27
JPH0411545B2 (da) 1992-02-28
PT75885A (fr) 1982-12-01
HU194549B (en) 1988-02-29
AR243249A1 (es) 1993-07-30
EP0080419B1 (fr) 1990-01-24
YU264882A (en) 1984-12-31

Similar Documents

Publication Publication Date Title
DE2814556A1 (de) Substituierte phenylessigsaeurederivate und verfahren zu deren herstellung
DE2554772A1 (de) Neue 4(1h)-chinolinderivate und verfahren zu ihrer herstellung
DE2302944C2 (de) 9,10-Dihydro-4-(1-subst.-4-piperidyliden)-4H-benzol [4,5] cyclohepta [1,2-b] thiophene, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2424806A1 (de) Antikoagulantien, verfahren zu ihrer herstellung und ihre verwendung
DE2543870A1 (de) Verfahren zur herstellung von 5-fluor-2-methyl-1-(p-methyl-sulfinylbenzyliden)-indenyl-3-essigsaeure
DD204920A5 (de) Verfahren zur herstellung von 8-halogenalkyl-4h-(1)-benzopyran-4-onen
Wilds et al. 2'-Ketodihydro-1, 2-cyclopentenonaphthalene and Derivatives of Naphtho [1.2-b] furan
DE3122995A1 (de) Verfahren zur herstellung von oxocyclopentenen
DE2652685C2 (da)
DE2729846C2 (de) Verfahren zur Herstellung von in 3-Stellung alkylsubstituierten cis-1-Hydroxy-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo [b,d] pyran-9-onen
DE2838276A1 (de) Beta -substituierte diketone, verfahren zu deren herstellung und diese enthaltende arzneimittel
EP0122388B1 (de) Verfahren zur Herstellung von vicinalen Polycarbonylverbindungen
EP0302227B1 (de) 5-Halogen-6-amino-nikotin-säurehalogenide, ihre Herstellung und ihre Verwendung
EP0061669B1 (de) Verbessertes Verfahren zur Herstellung von Cyclohexan-1,3-dionen sowie einige neue bicyclische Cyclohexan-1,3-dione
Barltrop et al. 37. 4-Hydroxy-2′: 3′-dimethoxybenz cyclo heptatrien-3-one, and related topics
US4171371A (en) Diketones
CH510009A (de) Verfahren zur Herstellung von neuen heterocyclischen Carbonsäuren
AT265299B (de) Verfahren zur Herstellung von neuen 3-Morpholinon- oder 3-Morpholinthionderivaten
AT371812B (de) Verfahren zur herstellung von neuen oxazolderivaten sowie ihren salzen
Fujimoto et al. An Intermediate in the Grignard Reaction
DE2820263C3 (de) Verfahren zur Herstellung von 9-Methoxy-7H-furo [3,2g] [1] -benzopyran-7-on (8-Methoxy-psoralen)
DE1793175A1 (de) Verfahren zur Herstellung von Furansaeure-Derivaten
AT222645B (de) Verfahren zur Herstellung von neuen, racemischen, spirocyclischen Triketonen
DE1470018C (de) 6 Chlor 7 sulfamyl 4 methoxy spiro eckige Klammer auf 2H 3,4 dihydro 1,2,4 benzothiadiazm 3,1 cyclohexan eckige Klam mer zu 1,1 dioxyd
DE2653177A1 (de) Verfahren zur herstellung von alkylsubstituierten beta-resorcylsaeureestern